For Your Health

委任醫師

學經歷

• 學歷

  • 國立陽明交通大學 醫學系
  • 朝陽科技大學 生化科技博士

  經歷

  • 臺中榮民總醫院 外科部住院醫師
  • 臺中榮民總醫院 外科部泌尿外科主治醫師兼主任
  • 日本齒醫科大學附屬市川綜合醫院進修：泌尿系統內視鏡手術
  • 美國紐約長島醫學中心進修：泌尿內視鏡手術、腹腔鏡之攝護腺全切除術、
  • 腹腔鏡之腎臟部分切除術

  現職

  • 彰化基督教醫院、台中榮民總醫院 泌尿外科 特約醫師、台中慈濟醫院 泌尿科 顧問醫師
  • 教育部部定副教授
  • 台灣泌尿科醫學會理事
  • 健保署審查委員
  • 台中市醫師公會會員代表

專長

• • 機器人及腹腔鏡微創手術
  • 泌尿道重建手術
  • 腎臟移植
  • 攝護腺疾病

  論文

  1. Lai, G. S., Li, J. R., Wang, S. S., Chen, C. S., Yang, C. K., Lin, C. Y., Hung, S. C.,Chiu, K. Y.,& Yang, S. F. Real world treatment sequences and outcomes for metastatic renal cell carcinoma. PLoS One. 2023 Mar 9;18(3):e0282745. doi: 10.1371/journal.pone.0282745. eCollection 2023.

  2. Lai, G. S., Li, J. R., Wang, S. S., Chen, C. S., Yang, C. K., Lin, C. Y., Hung, S. C., Ho, H. C., Ou, Y. C.,Chiu, K. Y.,& Yang, S. F. Influence of Surgical Complications on Outcomes in Kidney Transplantation Patients. In Vivo. 2023 Nov-Dec; 37(6): 2796–2802.Published online 2023 Nov 3. doi: 10.21873/invivo.13392

  3. Ni, H. F., Li, J. R., Wang, S. S., Hung, S. C., Yang, C. K., Chen, C. S., &Chiu, K. Y.*Prognostic Factors of Extramammary Paget's Disease: A Retrospective Study at a Medical Center in Taiwan. In Vivo. 2023 Nov-Dec;37(6):2786-2791. doi: 10.21873/invivo.13390.

  4. Lu, K.,* &Chiu, K. Y.Comparative Survival Analysis of Dialysis and Renal Transplantation in HBV-Infected End-Stage Renal Disease Patients. Transplant Proc. 2023 Dec;55(10):2429-2435. doi: 10.1016/j.transproceed.2023.09.015.

  5. Yang, H. C., Hsieh, H. C., Liao, P. C., Chang, L. W., Hu, J. C., Hung, S. C., Lin, C. Y., Wang, S. C., Chen, C. C., Yang, C. K., Wang, S. S., Chen, C. S., Lu, K., Li, J. R., Cheng, C. L., &Chiu, K. Y.*Nephroscope-assisted single trocar peritoneal dialysis catheter insertion improves catheter survival compared with laparoscopic technique: Ten-year experience of a single-center. Asian J Surg. 2024 Jan;47(1):303-309. doi: 10.1016/j.asjsur.2023.08.143. Epub 2023 Sep 7.

  6. Hsueh, C. H., Chang, L. W.,Chiu, K. Y.,Hung, S. C., Chen, J. P., & Li, J. R. Chronic kidney disease, preoperative use of antispasmodics and lower resected prostate volume ratios are risk factors for postoperative use of adrenergic Alpha-blockers and antispasmodics. PLoS One. 2023 Mar 9;18(3):e0282745. doi: 10.1371/journal.pone.0282745. eCollection 2023.

  7. Lu, K.,* &Chiu, K. Y.Lifetime Risk of Hepatorenal Events Assessed in Longitudinal Cohort of Renal Transplant Recipients with HBV Infection. Transplant Proc. 2023 Jun 26;S0041-1345(23)00418-9. doi: 10.1016/j.transproceed.2023.05.017.  Online ahead of print.

  8. Chiou, J. K., Chang, L. W., Li, J. R., Wang, S. S., Yang, C. K., Chen, C. S., Lu, K., Cheng, C. L.,Chiu, K. Y.,& Hung, S. C. Metastasectomy Improves Overall Survival in Metastatic Renal Cell Carcinoma: A Retrospective Cohort Study. Anticancer Res. 2023 Jul;43(7):3193-3201. doi: 10.21873/anticanres.16493.

  9. Lin, C. Y., Wang, C. L., Wang, S. S., Yang, C. K., Li, J. R., Chen, C. S., Hung, S. C., Chiu, K. Y., Cheng, C. L., Ou, Y. C., & Yang, S. F. WWOX Polymorphisms as Predictors of the Biochemical Recurrence of Localized Prostate Cancer after Radical Prostatectomy. Int J Med Sci, 2023 May 21;20(7):969-975. doi: 10.7150/ijms.84364.

  10. Antonarakis, E. S., Park, S. H., Goh, J. C., Shin, S. J., Lee, J. L., Mehra, N., McDermott, R., Sala-Gonzalez, N., Fong, P. C., Greil, R., Retz, M., Sade, J. P., Yanez, P., Huang, Y. H., Begbie, S. D., Gafanov, R. A., De Santis, M., Rosenbaum, E., Kolinsky, M. P., Rey, F.,Chiu, K.Y.,. . . Yu, E. Y. (2023). Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial. J Clin Oncol. 2023 Aug 1; 41(22): 3839–3850.Published online 2023 Jun 8. doi: 10.1200/JCO.23.00233

  11. Lu, K., &Chiu, K. Y.*Temporal trends of de novo urological malignancy in renal transplant recipients without a cancer history: A longitudinal cohort study. Clin Transplant. 2023 Jun 12; doi: 10.1111/ctr.15047. Online ahead of print.

  12. Yang, C. K., Yang, C. R., Ou, Y. C., Cheng, C.L., Ho, H.C.,Chiu, K.Y*.,Wang, S.S., Li, J.R., Chen, C.S., Hung, C.F., Chen, C.C., Wang, S.C., Lin, C.Y., & Hung, S.C. Prostate?specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high?risk and very high?risk prostate cancer. Oncology Letters. 2023 Jul 26;1;1792-1082. doi:10.3892/ol.2023.13870.

  13. Yen, T. H., Wang, S. S., Yang, C. K., Lu, K., Chen, C. S., Cheng, C. L., Hung, S. C.,Chiu, K. Y.,Chen, C. P., Yang, C. R., *& Li, J. R.* Risk analysis of subsequent therapies after first-line chemotherapy in advanced testicular cancer patients. J Chin Med Assoc. 2023 May;doi: 10.1097/JCMA.0000000000000938.

  14. Yang, H. C., Chang, L. W., Li, J. R., Wang, S. S., Yang, C. K., Chen, C. S., Lu, K., Chen, C. C., Wang, S. C., Lin, C. Y., Cheng, C. L., Ou, Y. C.,Chiu, K. Y.,& Hung, S. C.*Complete Cycles of Radium-223 Improve Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer: A Retrospective Study. Anticancer Res. 2023 Apr;43(4):1809-1816.

  15. Lin, Y. T., Hung, S. W., Liu, M. C.,Chiu, K. Y.,Chai, J. W., & Lin, J. C.*Feasibility of Computed Tomography-guided Percutaneous Renal Cryoablation Under Local Anesthesia: A Single Center Experience in Taiwan. Anticancer Res. 2023 Apr;43(4):1699-1708. doi: 10.21873/anticanres.16322.

  16. Chang, L. W., Hung, S. C., Chen, C. S., Li, J. R.,Chiu, K. Y.,Wang, S. S., Yang, C. K., Lu, K., Chen, C. C., Wang, S. C., Lin, C. Y., Cheng, C. L., Ou, Y. C., & Yang, S. F. Geriatric nutritional risk index as a prognostic marker for patients with upper tract urothelial carcinoma receiving radical nephroureterectomy. Sci Rep . 2023 Mar; 13(1):4554.

  17. Hsueh, C. H., Chang, L. W.,Chiu, K. Y.,Hung, S. C., Chen, J. P., & Li, J. R. Chronic kidney disease, preoperative use of antispasmodics and lower resected prostate volume ratios are risk factors for postoperative use of adrenergic Alpha-blockers and antispasmodics. PLoS One. 2023 Mar;18(3):e0282745.

  18. Lin, Y. T., Hung, S. W.,Chiu, K. Y.,Chai, J. W., & Lin, J. C. Assessment of Prostate Volume and Prostate-specific Antigen Density With the Segmentation Method on Magnetic Resonance Imaging. In Vivo. 2023 Mar-Apr;37(2):786-793. doi: 10.21873/invivo.13142.

  19. Li, J. R., Wang, S. S., Lu, K., Chen, C. S., Cheng, C. L., Hung, S. C.,Chiu, K. Y.,Hsu, C. Y., & Yang, C. K. First-line Chemotherapy Response Is Associated With Clinical Outcome During Immune Checkpoint Inhibitor Treatment in Advanced Urothelial Carcinoma: A Real World Retrospective Study. Anticancer Res. 2023 Mar;43(3):1331-1339.

  20. Chen, W. C., Li, J. R., Wang, S. S., Chen, C. S., Cheng, C. L., Hung, S. C., Lin, C. H.,Chiu, K. Y.,& Liao, P. C.* Conventional androgen deprivation therapy is associated with an increased risk of fracture in advanced prostate cancer, a nationwide population-based study. PLoS One, 2023 Jan;18(1): e0279981.

  21. Chang, L. W., Wang, S. S., Yang, C. K., Lu, K., Chen, C. S., Cheng, C. L., Hung, S. C.,Chiu, K. Y.,Hsu, C. Y., & Li, J. R. * Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate Hyperplasia. Anticancer Res, 2023 Jan;43(1): 485-491.